Annual Total Long Term Liabilities
$116.18 M
+$22.98 M+24.66%
31 December 2023
Summary:
Verve Therapeutics annual total long term liabilities is currently $116.18 million, with the most recent change of +$22.98 million (+24.66%) on 31 December 2023. During the last 3 years, it has fallen by -$18.83 million (-13.95%). VERV annual total long term liabilities is now -13.95% below its all-time high of $135.01 million, reached on 31 December 2020.VERV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$112.71 M
-$1.74 M-1.52%
30 September 2024
Summary:
Verve Therapeutics quarterly total long term liabilities is currently $112.71 million, with the most recent change of -$1.74 million (-1.52%) on 30 September 2024. Over the past year, it has dropped by -$4.75 million (-4.04%). VERV quarterly long term liabilities is now -50.55% below its all-time high of $227.92 million, reached on 31 March 2021.VERV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.7% | -4.0% |
| 3 y3 years | -13.9% | +1880.5% |
| 5 y5 years | - | - |
VERV Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -13.9% | +2346.9% | -4.5% | +5300.7% |
| 5 y | 5 years | -13.9% | +2346.9% | -50.5% | +5300.7% |
| alltime | all time | -13.9% | +2346.9% | -50.5% | +5300.7% |
Verve Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $112.71 M(-1.5%) |
| June 2024 | - | $114.45 M(-3.0%) |
| Mar 2024 | - | $117.99 M(+1.6%) |
| Dec 2023 | $116.18 M(+24.7%) | $116.18 M(-1.1%) |
| Sept 2023 | - | $117.46 M(+29.3%) |
| June 2023 | - | $90.88 M(-0.5%) |
| Mar 2023 | - | $91.35 M(-2.0%) |
| Dec 2022 | $93.20 M | $93.20 M(-3.3%) |
| Sept 2022 | - | $96.39 M(+4518.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $2.09 M(-31.5%) |
| Mar 2022 | - | $3.05 M(-35.8%) |
| Dec 2021 | $4.75 M(-96.5%) | $4.75 M(-16.6%) |
| Sept 2021 | - | $5.69 M(-54.4%) |
| June 2021 | - | $12.47 M(-94.5%) |
| Mar 2021 | - | $227.92 M(+68.8%) |
| Dec 2020 | $135.01 M(+258.6%) | - |
| Dec 2020 | - | $135.01 M |
| Dec 2019 | $37.65 M | - |
FAQ
- What is Verve Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Verve Therapeutics?
- What is Verve Therapeutics annual total long term liabilities year-on-year change?
- What is Verve Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Verve Therapeutics?
- What is Verve Therapeutics quarterly long term liabilities year-on-year change?
What is Verve Therapeutics annual total long term liabilities?
The current annual total long term liabilities of VERV is $116.18 M
What is the all time high annual total long term liabilities for Verve Therapeutics?
Verve Therapeutics all-time high annual total long term liabilities is $135.01 M
What is Verve Therapeutics annual total long term liabilities year-on-year change?
Over the past year, VERV annual total long term liabilities has changed by +$22.98 M (+24.66%)
What is Verve Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of VERV is $112.71 M
What is the all time high quarterly long term liabilities for Verve Therapeutics?
Verve Therapeutics all-time high quarterly total long term liabilities is $227.92 M
What is Verve Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, VERV quarterly total long term liabilities has changed by -$4.75 M (-4.04%)